Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer
- PMID: 38857055
- PMCID: PMC11168221
- DOI: 10.1080/15384047.2024.2366451
Role of transforming growth factor-β1 pathway in angiogenesis induced by chronic stress in colorectal cancer
Abstract
Background: Chronic stress can induce stress-related hormones; norepinephrine (NE) is considered to have the highest potential in cancer. NE can stimulate the expression of hypoxia-inducible factor-1α (HIF-1α), which is associated with vascular endothelial growth factor (VEGF) secretion and tumor angiogenesis. However, the underlying mechanisms are poorly understood.
Methods: Tumor-bearing mice were subjected to chronic restraint stress and treated with normal saline, human monoclonal VEGF-A neutralizing antibody bevacizumab, or β-adrenergic receptor (β-AR) antagonist (propranolol). Tumor growth and vessel density were also evaluated. Human colorectal adenocarcinoma cells were treated with NE, propranolol, or the inhibitor of transforming growth factor-β (TGF-β) receptor Type I kinase (Ly2157299) in vitro. TGF-β1 in mouse serum and cell culture supernatants was quantified using ELISA. The expression of HIF-1α was measured using Real time-PCR and western blotting. Cell migration and invasion were tested.
Results: Chronic restraint stress attenuated the efficacy of bevacizumab and promoted tumor growth and angiogenesis in a colorectal tumor model. Propranolol blocked this effect and inhibited TGF-β1 elevation caused by chronic restraint stress or NE. NE upregulated HIF-1α expression, which was reversed by propranolol or Ly2157299. Propranolol and Ly2157199 blocked NE-stimulated cancer cell migration and invasion.
Conclusions: Our results demonstrate the effect of NE on tumor angiogenesis and the critical role of TGF-β1 signaling during this process. In addition, β-AR/TGF-β1 signaling/HIF-1α/VEGF is a potential signaling pathway. This study also indicates that psychosocial stress might be a risk factor which weakens the efficacy of anti-angiogenic therapy.
Keywords: Chronic stress; angiogenesis; hypoxia inducible factor-1α; norepinephrine; transforming growth factor-β1.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.Cancer Lett. 2017 Sep 10;403:86-97. doi: 10.1016/j.canlet.2017.05.013. Epub 2017 Jun 7. Cancer Lett. 2017. PMID: 28602978
-
Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro.J Cancer Res Clin Oncol. 2016 Feb;142(2):423-35. doi: 10.1007/s00432-015-2044-9. Epub 2015 Sep 10. J Cancer Res Clin Oncol. 2016. PMID: 26358081
-
The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.Psychoneuroendocrinology. 2015 Feb;52:130-42. doi: 10.1016/j.psyneuen.2014.11.008. Epub 2014 Nov 16. Psychoneuroendocrinology. 2015. PMID: 25437118
-
Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.Oncogene. 2011 Mar 10;30(10):1213-28. doi: 10.1038/onc.2010.498. Epub 2010 Nov 8. Oncogene. 2011. PMID: 21057546
-
Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism.Int J Cancer. 2011 May 15;128(10):2306-16. doi: 10.1002/ijc.25589. Epub 2010 Oct 13. Int J Cancer. 2011. Retraction in: Int J Cancer. 2019 Sep 1;145(5):1452. doi: 10.1002/ijc.32297. PMID: 20715173 Retracted.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials